Filing Flows › Bio-Techne (TECH) › Q1 FY26
Bio-Techne (TECH) Q1 FY26 earnings results (first quarter fiscal 2026)
10-Q filed Nov 5, 2025
Bio-Techne (TECH) reported revenue of $287M for the first quarter fiscal 2026 (Q1 FY26), -1% from a year earlier and -10% from the quarter before. Operating margin was 16.6%, net earnings $38.2M (13.3% of revenue).
Bio-Techne, Q1 FY26: revenue $287M (-1% year over year), operating margin 16.6%, net earnings $38.2M, operating cash flow $27.6M. The chart follows the revenue to costs, profit and cash.
| Q1 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $287M | -10% | -1% |
| Gross profit | $188M | -5% | +3% |
| Operating profit | $47.7M | — | +19% |
| Net earnings | $38.2M | — | +14% |
| Operating cash flow | $27.6M | -72% | -57% |
| Free cash flow | $22.2M | -76% | -59% |
What changed
Revenue was $286.6M in Q1 FY26, down 1% year over year and down 10% from the previous quarter. Consumables was the largest line at 81% of revenue. Instruments lost $4.4M year over year (down 17%), 151% of the total change.
Gross margin was 65.6%, up 2.4 points from a year earlier. Operating profit was $47.7M, a 16.6% margin (up 2.8 points year over year). Operating expenses fell 2% while revenue fell 1%. Net earnings were $38.2M, up 14% year over year. The effective tax rate was 20.4%.
Operating cash flow was $27.6M (down 57% year over year), 72% of net earnings. Non-cash charges added back $24.3M of depreciation and amortization and $11.7M of share-based compensation. Working capital and other items used $46.6M. Capital expenditures of $5.4M left free cash flow of $22.2M.
Questions
What was Bio-Techne's revenue in the first quarter fiscal 2026?
Bio-Techne (TECH) reported revenue of $287M for the first quarter fiscal 2026 (Q1 FY26), -1% from a year earlier and -10% from the quarter before.
Was Bio-Techne profitable in the first quarter fiscal 2026?
Operating profit was $47.7M (16.6% of revenue) and net earnings $38.2M.
Source: Bio-Techne 10-Q on SEC EDGAR.